Girard R, Pedron T, Chaby R
Molecular Immunophysiology Unit, URA-359 of the National Centre for Scientific Research, Pasteur Institute, Paris, France.
Immunology. 1997 Jul;91(3):391-8. doi: 10.1046/j.1365-2567.1997.00275.x.
Although lipopolysaccharide (LPS)-induced overproduction of cytokines, involved in the pathogenesis of septic shock, occupies the spotlight of endotoxin research, another LPS effect, the differentiation of various cell types including haematopoietic bone marrow cells (BMC), which is probably related to its radioprotective activity, deserves equal attention. We have previously established that nanomolar concentrations of LPS trigger in human BMC the expression of CD14 by an induction mechanism independent of CD14 or any other molecule anchored to the cell membrane by a glycosyl phosphatidylinositol glycolipid. We now show that this LPS-induced stimulation is triggered by the binding of a small number of LPS molecules (13,000 molecules/cell) to constitutive LPS receptors of low affinity (Kd = 480 nM). This interaction, which was inhibited by a synthetic LPS antagonist, appeared specific, reversible, saturable, time- and temperature-dependent, but was independent of divalent cations, and was inhibited by serum. Exposure of BMC to LPS did not induce a down-modulation of these receptors, but enhanced their sensitivity to trypsin degradation. Inhibition of LPS binding following different treatments correlated with inhibition of BMC stimulation, thus suggesting that the sparse constitutive receptors of low affinity are efficient signalling receptors for LPS.
尽管脂多糖(LPS)诱导的细胞因子过度产生参与了脓毒症休克的发病机制,一直是内毒素研究的焦点,但LPS的另一个作用,即包括造血骨髓细胞(BMC)在内的各种细胞类型的分化,可能与其辐射防护活性有关,也值得同样关注。我们之前已经证实,纳摩尔浓度的LPS通过一种独立于CD14或任何其他通过糖基磷脂酰肌醇糖脂锚定在细胞膜上的分子的诱导机制,触发人BMC中CD14的表达。我们现在表明,这种LPS诱导的刺激是由少量LPS分子(13,000个分子/细胞)与低亲和力(Kd = 480 nM)的组成型LPS受体结合所触发的。这种相互作用被一种合成LPS拮抗剂抑制,似乎具有特异性、可逆性、饱和性、时间和温度依赖性,但不依赖于二价阳离子,且被血清抑制。将BMC暴露于LPS不会诱导这些受体的下调,但会增强它们对胰蛋白酶降解的敏感性。不同处理后LPS结合的抑制与BMC刺激的抑制相关,因此表明稀疏的低亲和力组成型受体是LPS的有效信号受体。